Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era

類似資料

• The Impact of Re-induction Prior to Salvage Autologous Stem Cell Transplantation in Multiple Myeloma
  著者:: Miller, Kevin C., 等
  出版事項: (2019)
• Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation
  著者:: Chakraborty, Rajshekhar, 等
  出版事項: (2017)
• Impact of additional cytoreduction following autologous SCT in multiple myeloma
  著者:: Kumar, SK, 等
  出版事項: (2008)
• Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant
  著者:: Al Saleh, Abdullah S., 等
  出版事項: (2020)
• Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
  著者:: Sidiqi, M. Hasib, 等
  出版事項: (2018)